• Je něco špatně v tomto záznamu ?

Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states

M. Holeček

. 2023 ; 145 (-) : 155614. [pub] 20230605

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016720

Gluconeogenesis, a pathway for glucose synthesis from non-carbohydrate substances, begins with the synthesis of oxaloacetate (OA) from pyruvate and intermediates of citric acid cycle in hepatocyte mitochondria. The traditional view is that OA does not cross the mitochondrial membrane and must be shuttled to the cytosol, where most enzymes involved in gluconeogenesis are compartmentalized, in the form of malate. Thus, the possibility of transporting OA in the form of aspartate has been ignored. In the article is shown that malate supply to the cytosol increases only when fatty acid oxidation in the liver is activated, such as during starvation or untreated diabetes. Alternatively, aspartate synthesized from OA by mitochondrial aspartate aminotransferase (AST) is transported to the cytosol in exchange for glutamate via the aspartate-glutamate carrier 2 (AGC2). If the main substrate for gluconeogenesis is an amino acid, aspartate is converted to OA via urea cycle, therefore, ammonia detoxification and gluconeogenesis are simultaneously activated. If the main substrate is lactate, OA is synthesized by cytosolic AST, glutamate is transported to the mitochondria through AGC2, and nitrogen is not lost. It is concluded that, compared to malate, aspartate is a more suitable form of OA transport from the mitochondria for gluconeogenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016720
003      
CZ-PrNML
005      
20231026105613.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.metabol.2023.155614 $2 doi
035    __
$a (PubMed)37286128
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Holeček, Milan $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic. Electronic address: holecek@lfhk.cuni.cz
245    10
$a Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states / $c M. Holeček
520    9_
$a Gluconeogenesis, a pathway for glucose synthesis from non-carbohydrate substances, begins with the synthesis of oxaloacetate (OA) from pyruvate and intermediates of citric acid cycle in hepatocyte mitochondria. The traditional view is that OA does not cross the mitochondrial membrane and must be shuttled to the cytosol, where most enzymes involved in gluconeogenesis are compartmentalized, in the form of malate. Thus, the possibility of transporting OA in the form of aspartate has been ignored. In the article is shown that malate supply to the cytosol increases only when fatty acid oxidation in the liver is activated, such as during starvation or untreated diabetes. Alternatively, aspartate synthesized from OA by mitochondrial aspartate aminotransferase (AST) is transported to the cytosol in exchange for glutamate via the aspartate-glutamate carrier 2 (AGC2). If the main substrate for gluconeogenesis is an amino acid, aspartate is converted to OA via urea cycle, therefore, ammonia detoxification and gluconeogenesis are simultaneously activated. If the main substrate is lactate, OA is synthesized by cytosolic AST, glutamate is transported to the mitochondria through AGC2, and nitrogen is not lost. It is concluded that, compared to malate, aspartate is a more suitable form of OA transport from the mitochondria for gluconeogenesis.
650    12
$a glukoneogeneze $7 D005943
650    12
$a kyselina aspartová $x metabolismus $7 D001224
650    _2
$a maláty $7 D008293
650    _2
$a glutamáty $x metabolismus $7 D005971
650    _2
$a kyselina pyrohroznová $7 D019289
650    _2
$a kyselina mléčná $7 D019344
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
773    0_
$w MED00010225 $t Metabolism: clinical and experimental $x 1532-8600 $g Roč. 145, č. - (2023), s. 155614
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37286128 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105608 $b ABA008
999    __
$a ok $b bmc $g 2000313 $s 1203082
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 145 $c - $d 155614 $e 20230605 $i 1532-8600 $m Metabolism, clinical and experimental $n Metabolism $x MED00010225
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...